ONTTF News and Press, Oxford Nanopore From 03/22/22

Oxford Nanopore Technologies Limited (ONTTF) Q4 2021 Results Conference Call March 22, 2022 05:30 AM ET Company Participants Gordon Sanghera - Chief Executive Officer Tim Cowper - Chief Financial Officer Conference Call Participants Steean Hamill - Numis Charles Weston - RBC James Gordon - JP...

Researchers Use Oxford Nanopore Technology To Develop a Single Test Method To Characterise More Than 50 Genetic Diseases In a Study Published in Science Advances, a Team From the Garvan Institute of Medical Research, Australia, Has Described How Their Method Using Nanopore Sequencing Te...

Scientists describe new approach in NEJM, using Oxford Nanopore DNA sequencing technology to improve prognosis in critically ill patients, in less than 8 hours Oxford Nanopore worked with a team led by Stanford University School of Medicine in a research study to develop a rapid, whole ...

Oxford Nanopore Technologies is a developer of a new-generation nanopore-based sensing technology. The company’s technology is used in more than 100 countries for real-time and scalable analysis of DNA and RNA. The company is a spin-out from the University of Oxford and emp...

OXFORD, UK / ACCESSWIRE / December 2, 2021 / Highlights include release of new "Kit 12" and R10.4 flow cells for >Q20 (>99%) raw read and around Q30 (99.9%) Duplex sequencing accuracy, and the new PromethION P2 device, a palm-sized, high-throughput sequencer that delivers the most acce...

The revolutionary technology of synthetic biology is poised to make a profound impact on the way a vast array of products are manufactured, from lab-grown meat to cosmetics to biodegradable packaging. Like the internet revolution, companies that enable or effectively harness synthetic...